{"id":64854,"date":"2024-11-02T12:22:58","date_gmt":"2024-11-02T12:22:58","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=64854"},"modified":"2026-04-30T10:15:58","modified_gmt":"2026-04-30T10:15:58","slug":"raloxiheal","status":"publish","type":"product","link":"https:\/\/medsbase.com\/da\/raloxiheal\/","title":{"rendered":"Raloxiheal"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:18px 0;border-radius:4px;\">\n<p style=\"margin:0 0 8px 0;\"><strong>\ud83d\udca1 Hurtigt svar<\/strong><\/p>\n<p style=\"margin:0;\"><strong>Raloxiheal<\/strong> er <strong>raloxifene 60 mg<\/strong>, a selective estrogen receptor modulator (SERM) with dual approval: <strong>prevention and treatment of postmenopausal osteoporosis<\/strong>, og <strong>reduction of invasive breast cancer risk<\/strong> in high-risk postmenopausal women. Unlike estrogen, raloxifene is NOT an HRT for hot flushes \u2014 it can worsen them. Safer breast-cancer profile than estrogen, but comparable VTE risk.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>Hvad du f\u00e5r med MedsBase:<\/strong> WHO-GMP certificeret producent \u00b7 Diskret emballage \u00b7 Verdensomsp\u00e6ndende forsendelse \u00b7 1.400+ verificerede <a href=\"https:\/\/medsbase.com\/da\/reviews\/\">kundeanmeldelser<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Hver ordre er d\u00e6kket af vores <a href=\"https:\/\/medsbase.com\/da\/medsbase-re-shipment-assurance-policy\/\"><strong>Reshipment Assurance Policy<\/strong><\/a> \u2014 hvis din pakke ikke ankommer inden for 20 hverdage, sender vi en erstatning.<\/p>\n<div style=\"background:#f4f8fb;border-left:4px solid #2c7cb0;padding:14px 20px;margin:16px 0;border-radius:4px;font-size:0.95em;\">\n<strong>\ud83d\udd12 Hvad du f\u00e5r med MedsBase:<\/strong> WHO-GMP certificeret producent \u00b7 Diskret neutral emballage (ingen medicinnavn p\u00e5 ydersiden) \u00b7 Verdensomsp\u00e6ndende forsendelse \u00b7 L\u00e6s vores <a href=\"https:\/\/medsbase.com\/da\/reviews\/\">1.400+ kundeanmeldelser<\/a>\n<\/div>\n<h3>Hvorfor bestille fra MedsBase<\/h3>\n<p>Hver MedsBase-ordre sendes fra en WHO-GMP-certificeret producent i neutral, fuldst\u00e6ndig diskret emballage \u2014 intet p\u00e5 ydersiden identificerer indholdet eller apoteket. Kortbetalinger behandles via en reguleret crypto-on-ramp; beskrivelsen p\u00e5 din bankudtastning er processorens navn (en reguleret kortbetalingsprocessor) \u2014 aldrig \u201cMedsBase\u201d eller noget apoteksrelateret. Kryptobetalinger via Plisio forbliver fuldst\u00e6ndig anonyme. Hver pakke er d\u00e6kket af vores <a href=\"https:\/\/medsbase.com\/da\/medsbase-re-shipment-assurance-policy\/\">Reshipment Assurance Policy<\/a>.<\/p>\n<h2><strong>What Is Raloxiheal?<\/strong><\/h2>\n<p>Raloxiheal is a branded generic of <strong>raloxifene 60 mg<\/strong>, en <strong>selective estrogen receptor modulator (SERM)<\/strong>. SERMs have estrogen-like effects in some tissues and anti-estrogen effects in others. Raloxifene mimics estrogen in bone (positive \u2014 builds density) but blocks estrogen in breast tissue (positive \u2014 reduces breast cancer risk). It has neutral or mild effects on the uterus (unlike tamoxifen, which carries endometrial cancer risk). Manufactured by Healing Pharma.<\/p>\n<h2><strong>FDA-Approved Indications<\/strong><\/h2>\n<ul>\n<li><strong>Forebyggelse af postmenopausalt osteoporose<\/strong> \u2014 typically in women 5+ years past menopause with moderate bone-density loss.<\/li>\n<li><strong>Treatment of postmenopausal osteoporosis<\/strong> \u2014 reduces vertebral fracture risk by ~40\u201350% over 3 years.<\/li>\n<li><strong>Reduction of invasive breast cancer risk<\/strong> in postmenopausal women at high risk. The STAR trial showed raloxifene 60 mg reduced invasive breast cancer risk ~50% (similar to tamoxifen) with fewer thromboembolic events and less endometrial cancer risk.<\/li>\n<\/ul>\n<h2><strong>When Raloxifene Is Right For You<\/strong><\/h2>\n<ul>\n<li><strong>You have<\/strong>: osteoporosis OR high breast cancer risk, age \u226560 or at least 5 years post-menopause<\/li>\n<li><strong>You do not have<\/strong>: active hot flushes (raloxifene worsens them), VTE history, active liver disease, pregnancy potential<\/li>\n<li><strong>Alternatives:<\/strong> bisphosphonates (alendronate, risedronate), denosumab, teriparatide for osteoporosis; tamoxifen as alternative SERM for breast cancer prevention (premenopausal option)<\/li>\n<\/ul>\n<h2><strong>S\u00e5dan indtages<\/strong><\/h2>\n<ol>\n<li>Tag <strong>one 60 mg tablet once daily<\/strong>, at any time, with or without food.<\/li>\n<li>Take with adequate calcium (1000\u20131200 mg\/day) and vitamin D (800\u20131000 IU\/day) \u2014 raloxifene works better with sufficient bone substrate.<\/li>\n<li>Effects on bone density appear at 6\u201312 months; fracture risk reduction is continuous with ongoing use.<\/li>\n<li>Breast cancer risk reduction begins within months; maintained over years of use.<\/li>\n<li>Typical duration: <strong>5 \u00e5r<\/strong> for bone indications; <strong>up to 5 years<\/strong> for breast cancer risk reduction.<\/li>\n<\/ol>\n<h2><strong>Bivirkninger<\/strong><\/h2>\n<p><strong>Almindelige:<\/strong> hot flushes (new onset or worsening \u2014 up to 25%), leg cramps, peripheral oedema, flu-like symptoms, joint pain, sweating.<\/p>\n<p><strong>Mindre almindelige:<\/strong> breast tenderness, depression, rash.<\/p>\n<p><strong>Alvorlige (sj\u00e6ldne):<\/strong> VTE (DVT, PE) \u2014 risk similar to estrogen; fatal stroke in postmenopausal women with coronary heart disease (RUTH trial); retinal vein thrombosis.<\/p>\n<h2><strong>Who Should Not Take Raloxiheal<\/strong><\/h2>\n<ul>\n<li><strong>Active or history of VTE (DVT, PE)<\/strong> \u2014 raloxifene raises risk 2\u20133\u00d7<\/li>\n<li>Women with history of stroke (RUTH trial showed increased stroke fatality in women with coronary heart disease)<\/li>\n<li>Pregnancy or women who might become pregnant<\/li>\n<li>Children and adolescents<\/li>\n<li>Aktiv leversygdom<\/li>\n<li>Sv\u00e6r nyreinsufficiens<\/li>\n<li>Undiagnosed vaginal bleeding (investigate first)<\/li>\n<li>Active breast or endometrial cancer (discuss individually)<\/li>\n<\/ul>\n<h2><strong>Raloxifene vs Alternatives \u2014 Decision Table<\/strong><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:12px 0;\">\n<tr style=\"background:#2c7cb0;color:#fff;\">\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Goal<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">F\u00f8rstevalg<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Raloxifene&#8217;s role<\/th>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Vasomotor (hot flush) relief<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Estrogen \/ tibolone<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Not indicated \u2014 worsens hot flushes<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:10px;border:1px solid #ddd;\">Postmenopausal osteoporose<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Alendronate \/ other bisphosphonates<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Good alternative; strongest evidence for vertebral fracture<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Risikoreduktion for brystkr\u00e6ft<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Tamoxifen (premenopausal) or raloxifene (postmenopausal)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Better side-effect profile than tamoxifen for postmenopausal use<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:10px;border:1px solid #ddd;\">Combined bone + breast cancer goals<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Raloxifene<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Single drug covers both<\/td>\n<\/tr>\n<\/table>\n<h2><strong>Opbevaring<\/strong><\/h2>\n<p>Store at room temperature (15\u201325 \u00b0C). Keep in original blister, away from moisture and light. Keep out of reach of children.<\/p>\n<h2 id=\"faqs\">Ofte stillede sp\u00f8rgsm\u00e5l<\/h2>\n<h3 class=\"wp-block-heading\">Is raloxifene the same as estrogen?<\/h3>\n<p>No \u2014 it is a selective estrogen receptor modulator (SERM). It acts like estrogen in bone (positive) but blocks estrogen in breast tissue (also positive, for cancer risk reduction). Uterine effect is neutral. Unlike estrogen, it does NOT treat hot flushes \u2014 it often worsens them.<\/p>\n<h3 class=\"wp-block-heading\">Will raloxifene cause hot flushes?<\/h3>\n<p>Yes, in ~25% of users \u2014 either new-onset or worsening of existing flushes. This is the classic raloxifene trade-off: you get bone and breast protection but not symptom relief.<\/p>\n<h3 class=\"wp-block-heading\">Can I combine raloxifene with estrogen?<\/h3>\n<p>No \u2014 combination negates the benefits. If you need hot flush relief AND bone protection, discuss options with a clinician: short-term estrogen first, then switch to raloxifene or bisphosphonate.<\/p>\n<h3 class=\"wp-block-heading\">How long do I need to take Raloxiheal?<\/h3>\n<p>Typical courses are 3\u20135 years for osteoporosis; 5 years for breast cancer prevention. Longer duration is fine for ongoing osteoporosis protection.<\/p>\n<h3 class=\"wp-block-heading\">What about calcium and vitamin D?<\/h3>\n<p>Yes \u2014 raloxifene works best combined with adequate calcium (1000\u20131200 mg\/day) and vitamin D (800\u20131000 IU\/day). These provide the substrate raloxifene helps retain.<\/p>\n<h3 class=\"wp-block-heading\">Does raloxifene reduce hip fracture risk?<\/h3>\n<p>Trial data (MORE, CORE) show strong vertebral fracture reduction (~40\u201350%) but less conclusive effect on hip fracture. For hip-fracture-focused protection, bisphosphonates or denosumab may be preferred.<\/p>\n<h3 class=\"wp-block-heading\">What is the VTE risk?<\/h3>\n<p>Raloxifene raises VTE risk ~2\u20133\u00d7 (similar to estrogen). Risk is highest in the first 4 months. Stop raloxifene 3 days before prolonged immobilisation, surgery, or long flights; resume when mobile.<\/p>\n<h3 class=\"wp-block-heading\">Is raloxifene safer than tamoxifen for breast cancer prevention?<\/h3>\n<p>For postmenopausal women, yes \u2014 raloxifene has lower endometrial cancer risk and fewer thromboembolic events vs tamoxifen, with similar invasive breast cancer risk reduction (STAR trial).<\/p>\n<h3 class=\"wp-block-heading\">Relaterede hormon- og kvindersundhedsprodukter<\/h3>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/da\/premarin\/\">Premarin (Konjugerede \u00f8strogener)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/da\/premarin-cream\/\">Premarin Cream (Vaginalt \u00f8strogen)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/da\/progynova\/\">Progynova (Estradiolvalerat)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/da\/endogest\/\">Endogest (Progesteron 100 mg)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/da\/gestoford\/\">Gestoford (Progesteron 100 mg)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/da\/gestheal\/\">Gestheal (Progesteron 200 mg)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/da\/susten-capsule\/\">Susten Capsule (Progesteron)<\/a><\/li>\n<\/ul>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:14px 20px;margin:16px 0;border-radius:4px;font-size:0.9em;\">\n<p style=\"margin:0;\"><strong>\u2695\ufe0f Medicinsk ansvarsfraskrivelse:<\/strong> Informationen er vejledende og erstatter ikke l\u00e6gevejledning. Hormonbehandlinger medf\u00f8rer specifikke risici (brystkr\u00e6ft, VTE, slagtilf\u00e6lde, livmoderhalskr\u00e6ft ved uafbalanceret \u00f8strogen) \u2014 konsulter en l\u00e6ge f\u00f8r start, stop eller \u00e6ndring af hormonmedicin. Den individuelle risiko-fordelingsprofil afh\u00e6nger af personlig og familie medicinsk historie.<\/p>\n<\/div>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Relaterede alternativer<\/h3>\n<p>Andre produkter inden for <strong>Kroniske tilstande<\/strong> som kunder ogs\u00e5 ser:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/da\/foracort-inhaler\/\">Foracort Inhaler<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/da\/hytrin\/\">Hytrin<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/da\/dilzem-cd\/\">Dilzem CD<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/da\/calpol\/\">Calpol<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/da\/betnesol-tab\/\">Betnesol-tablet<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>\u2705 St\u00f8tter knoglesundhed<br \/>\n\u2705 Reducerer risikoen for knoglebrud<br \/>\n\u2705 S\u00e6nker kolesterolniveauet<br \/>\n\u2705 Forebygger osteoporose<br \/>\n\u2705 Menopause symptom relief<\/p>\n<p>Raloxiheal contains <strong>Raloxifene<\/strong>.<\/p>","protected":false},"featured_media":64855,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[3223,3519,3502],"product_tag":[5324,5323],"class_list":{"0":"post-64854","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-chronic-conditions","7":"product_cat-hormone-replacement-therapy-hrt-medication-for-menopause","8":"product_cat-womens-health","9":"product_tag-raloxifene","10":"product_tag-raloxiheal","12":"first","13":"instock","14":"shipping-taxable","15":"purchasable","16":"product-type-variable","17":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/product\/64854","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/comments?post=64854"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/media\/64855"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/media?parent=64854"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/product_brand?post=64854"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/product_cat?post=64854"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/product_tag?post=64854"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}